ZVSA - ZyVersa Therapeutics Inc

0.3113
-0.238   -76.357%

Share volume: 12,453,600
Last Updated: 07-16-2025
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$0.55
-0.24
-0.43%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 35%
Dept financing 43%
Liquidity 8%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
-66.88%
2 Year
-96.40%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
$0.27 - $0.56
EPS 
-$11.13
52 WEEK RANGE
$0.27 - $1.94
52 WEEK CHANGE
-$66.88
MARKET CAP 
1.190 M
YIELD 
N/A
SHARES OUTSTANDING 
8.096 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Daniel J. O'Connor
Region: US
Website: lsprhealth.com
Employees: 2
IPO year: 2025
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Larkspur Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.

Recent news